Fabrinet (FN) Options Chain & Prices $713.83 +17.76 (+2.55%) As of 02:30 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FN Put and Call Options List 12/18/2026 11/20/2026 10/16/2026 7/17/2026 6/18/2026 5/15/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades5/15/2026$570.00$0.779Put26187176(+0)142.75% (+41.18%)-0.027431125/15/2026$580.00$0.977Put269493(+9)137.59% (+38.59%)-0.034481125/15/2026$580.00$116.569Call2 - - 22(+0)137.59% (+38.59%)0.96521925/15/2026$590.00$1.235Put122465(+5)132.57% (+35.84%)-0.043557105/15/2026$590.00$106.830Call1 - - 11(+0)132.57% (+35.84%)0.95613215/15/2026$600.00$1.572Put581230351(-9)127.73% (+32.90%)-0.05527315/15/2026$600.00$97.172Call2 - - 31(-1)127.73% (+32.90%)0.94441125/15/2026$610.00$2.018Put56 - 2588(-56)123.07% (+29.77%)-0.07041155/15/2026$610.00$87.622Call31 - 154(+128)123.07% (+29.77%)0.92926735/15/2026$620.00$2.610Put792858(+2)118.65% (+26.46%)-0.08998142 Get the Latest News and Ratings for FN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fabrinet and its competitors with MarketBeat's FREE daily newsletter. 5/15/2026$620.00$78.219Call51137(+3)118.65% (+26.46%)0.90969355/15/2026$630.00$3.403Put201773(-18)114.49% (+23.00%)-0.115186105/15/2026$630.00$69.016Call33 - 36(+2)114.49% (+23.00%)0.88448935/15/2026$640.00$4.467Put8917176(-1)110.67% (+19.45%)-0.147388215/15/2026$640.00$60.084Call31193(-59)110.67% (+19.45%)0.8522935/15/2026$650.00$5.894Put131379(-2)107.24% (+15.92%)-0.187971105/15/2026$650.00$51.515Call168343(+0)107.24% (+15.92%)0.811712105/15/2026$660.00$7.800Put26 - - 57(-4)104.29% (+12.51%)-0.2380345/15/2026$660.00$43.425Call235546(-2)104.29% (+12.51%)0.761664105/15/2026$670.00$10.317Put5 - 2495(-1)101.91% (+9.36%)-0.2978955/15/2026$670.00$35.946Call25713271(+7)101.91% (+9.36%)0.701823165/15/2026$680.00$13.578Put91 - 29(+0)100.17% (+6.60%)-0.36657955/15/2026$680.00$29.212Call10141557(+11)100.17% (+6.60%)0.633166415/15/2026$690.00$17.696Put1 - - 51(+0)99.14% (+4.34%)-0.4415115/15/2026$690.00$23.332Call5 - 564(-1)99.14% (+4.34%)0.55828445/15/2026$700.00$22.858Put112157(-2)98.82% (+2.63%)-0.52069755/15/2026$700.00$18.366Call3216793(-1)98.82% (+2.63%)0.481119235/15/2026$710.00$28.662Put2 - 152(+0)99.19% (+1.47%)-0.59386625/15/2026$710.00$14.304Call193543(+0)99.19% (+1.47%)0.40607995/15/2026$720.00$35.602Put1 - - 34(+0)100.20% (+0.86%)-0.66483215/15/2026$720.00$11.072Call163872(-1)100.17% (+0.82%)0.336921105/15/2026$730.00$43.100Put1 - - 21(+0)101.71% (+0.66%)-0.72561615/15/2026$730.00$8.553Call2912667(-1)101.66% (+0.62%)0.276024135/15/2026$740.00$6.618Call85122(-2)103.56% (+0.76%)0.22427455/15/2026$750.00$59.499Put42214(+0)105.76% (+1.18%)-0.81889835/15/2026$750.00$5.141Call1035110(+0)105.76% (+1.18%)0.18141675/15/2026$760.00$4.017Call41 - 56(+0)108.18% (+1.80%)0.14653425/15/2026$770.00$3.160Call4 - 116(-1)110.77% (+2.57%)0.11845425/15/2026$780.00$86.867Put1 - - 0(+0)113.46% (+3.45%)-0.90448515/15/2026$780.00$2.487Call76148(-3)113.54% (+3.52%)0.095413NNVC FDA = New Momentum Wave! (Ad)NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.See why this FDA milestone could be a catalyst for NNVC5/15/2026$790.00$1.999Call4092649(+0)116.23% (+4.39%)0.07802955/15/2026$800.00$105.974Put1 - - 2(+0)119.03% (+5.38%)-0.93681815/15/2026$800.00$1.607Call61 - 91(+0)119.03% (+5.38%)0.06369465/15/2026$840.00$0.719Call3 - 363(+0)130.28% (+9.54%)0.029591End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies ABNB Options Data LITE Options Data MTSI Options Data ZS Options Data CLS Options Data JBL Options Data TTMI Options Data TRMB Options Data SANM Options Data PLXS Options Data Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:FN) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersJ.P. Morgan is betting on this coinFor the first time in history, autonomous AI programs can hold, send, and receive funds — completely without h...Crypto 101 Media | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...Equiscreen | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredCollect $1,170 a month from silverI've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fabrinet Please log in to your account or sign up in order to add this asset to your watchlist. Share Fabrinet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
